Wang WS - Search Results

1

Transarterial chemoembolization failure/refractoriness: A scientific concept or pseudo-proposition.

Zhang S, Zhong BY, Zhang L, Wang WS, Ni CF. Zhang S, et al. Among authors: wang ws. World J Gastrointest Surg. 2022 Jun 27;14(6):528-537. doi: 10.4240/wjgs.v14.i6.528. World J Gastrointest Surg. 2022. PMID: 35979416 Free PMC article. Review.

2

Feasibility of Helical I-125 Seed Implant in the Portal Vein.

Wang C, Wang W, Shen J, Ren B, Zhu X, Ni C. Wang C, et al. Cardiovasc Intervent Radiol. 2019 Jan;42(1):121-129. doi: 10.1007/s00270-018-2059-0. Epub 2018 Aug 30. Cardiovasc Intervent Radiol. 2019. PMID: 30167775

3

ROR1 is highly expressed in circulating tumor cells and promotes invasion of pancreatic cancer.

Xu GL, Shen J, Xu YH, Wang WS, Ni CF. Xu GL, et al. Among authors: wang ws. Mol Med Rep. 2018 Dec;18(6):5087-5094. doi: 10.3892/mmr.2018.9500. Epub 2018 Sep 20. Mol Med Rep. 2018. PMID: 30272313

4

High Epithelial Cell Adhesion Molecule-Positive Circulating Tumor Cell Count Predicts Poor Survival of Patients with Unresectable Hepatocellular Carcinoma Treated with Transcatheter Arterial Chemoembolization.

Shen J, Wang WS, Zhu XL, Ni CF. Shen J, et al. Among authors: wang ws. J Vasc Interv Radiol. 2018 Dec;29(12):1678-1684. doi: 10.1016/j.jvir.2018.07.030. Epub 2018 Nov 2. J Vasc Interv Radiol. 2018. PMID: 30392801

5

Transarterial Chemoembolization (TACE) Combined with Sorafenib versus TACE Alone for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Study.

Ren B, Wang W, Shen J, Li W, Ni C, Zhu X. Ren B, et al. J Cancer. 2019 Jan 29;10(5):1189-1196. doi: 10.7150/jca.28994. eCollection 2019. J Cancer. 2019. PMID: 30854128 Free PMC article.

6

Safety and Feasibility of Helical I-125 Seed Implants Combined with Transcatheter Arterial Chemoembolization in Hepatocellular Carcinomas with Main Portal Vein Tumor Thrombus.

Wang W, Shen J, Wang C, Ren B, Zhu X, Ni C. Wang W, et al. Cardiovasc Intervent Radiol. 2019 Oct;42(10):1420-1428. doi: 10.1007/s00270-019-02256-z. Epub 2019 Jun 11. Cardiovasc Intervent Radiol. 2019. PMID: 31187228

7

In vivo evaluation of callispheres microspheres in the porcine renal artery embolization model.

Ren B, Wang W, Shen J, Ni C, Zhu X. Ren B, et al. Am J Transl Res. 2019 Jul 15;11(7):4166-4179. eCollection 2019. Am J Transl Res. 2019. PMID: 31396326 Free PMC article.

8

Feasibility and Short-Term Stability of Portal Vein Infusion Port Placement by Transjugular Access.

Wang WS, Zhu XL, Shen J, Li MM, Tang HH, Li WC, Miao JC, Wei WX, Ni CF. Wang WS, et al. J Vasc Interv Radiol. 2020 Mar;31(3):425-429. doi: 10.1016/j.jvir.2019.08.021. Epub 2020 Jan 22. J Vasc Interv Radiol. 2020. PMID: 31982318

9

Prognosis Nomogram for Hepatocellular Carcinoma Patients with Portal Vein Invasion Undergoing Transarterial Chemoembolization Plus Sorafenib Treatment: A Retrospective Multicentre Study.

Zhang L, Sun JH, Hou ZH, Zhong BY, Yang MJ, Zhou GH, Wang WS, Huang P, Zhang S, Li Z, Zhu XL, Yan ZP, Ni CF. Zhang L, et al. Among authors: wang ws. Cardiovasc Intervent Radiol. 2021 Jan;44(1):63-72. doi: 10.1007/s00270-020-02579-2. Epub 2020 Sep 23. Cardiovasc Intervent Radiol. 2021. PMID: 32965582

10

Deep Learning Predicts Overall Survival of Patients With Unresectable Hepatocellular Carcinoma Treated by Transarterial Chemoembolization Plus Sorafenib.

Zhang L, Xia W, Yan ZP, Sun JH, Zhong BY, Hou ZH, Yang MJ, Zhou GH, Wang WS, Zhao XY, Jian JM, Huang P, Zhang R, Zhang S, Zhang JY, Li Z, Zhu XL, Gao X, Ni CF. Zhang L, et al. Among authors: wang ws. Front Oncol. 2020 Sep 30;10:593292. doi: 10.3389/fonc.2020.593292. eCollection 2020. Front Oncol. 2020. PMID: 33102242 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

553 results

Search Page